Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphoma

Thomas E. Witzig, Christine A. White, Leo I. Gordon, Gregory A. Wiseman, Christos Emmanouilides, James L. Murray, John Lister, Pratik S. Multani

Research output: Contribution to journal › Article › peer-review

261 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences